ArticleScientific reports2024

Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-Akt pathway activation.

Ruijuan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.